MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi 
KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder
CELEBRATION, Fla., Dec. 22, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company engaged in the discovery...
Resverlogix Announces Apabetalone Treatment Prior to SARS-CoV-2 (COVID-19) Exposure Significantly Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
Latest publication confirms BET inhibitors reduce the levels of critical receptors used by SARS-CoV-2 (COVID-19) to gain entry into cells,...
ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
Beyond retinal detachment, lead candidate ONL1204 will also advance into the chronic conditions of glaucoma and dry age-related macular degeneration...
FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2
SAN FRANCISCO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced dosing of the first patient in the...
THC Therapeutics, Inc. Independently Tested, Patented Sanitizing Cannabis Dryer More Relevant Than Ever
The dHydronator’s SanitiZen® technology has been proven to reduce the microbial load level of cannabis from failing laboratory testing and...
BioCryst Provides Update on Galidesivir Program
RESEARCH TRIANGLE PARK, N.C., Dec. 22, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that data from part...
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
Conference Call and Webcast To be Held Monday, December 28th, 2020 4:30 pm Eastern TimeNEW YORK, Dec. 22, 2020 (GLOBE...
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
-- Study met primary endpoint and all key secondary endpoints with statistically significant and clinically meaningful reductions in weight and...
PolyPid Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy Program
Single Local Treatment of OncoPLEX Showed Improved Overall Survival and Significantly Less Tumor Recurrence, and Reduced Systemic Toxicity Compared to...
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)
University of Geneva Technology Covers Broad Applications for Cardiometabolic SyndromesCHATHAM, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding...
HEXO Corp Announces Lapse of Base Shelf Prospectus
OTTAWA, Dec. 22, 2020 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE:HEXO) announces that its amended...
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 NEWCASTLE UPON TYNE, UK,...
Allarity Therapeutics Draws Down the Third Tranche Under Its Convertible Note Agreement with Negma Group LTD and Park Partners GP
Press Release Hørsholm, Denmark (22 December 2020) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that it...
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx(TM)
Study results are expected to support the Company's plans to file an IND application with the FDA for a Phase...
NextGen Healthcare, Inc. to Participate in the 39th Annual Virtual J.P. Morgan Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--$NXGN #AmbulatoryHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that President and...
Siemens Government Technologies Honored as a Top Technology Company in the Greater Washington Region by the Northern Virginia Technology Council
RESTON, Va.--(BUSINESS WIRE)--Siemens Government Technologies (SGT), Inc. – the federally-focused U.S. arm of technology powerhouse Siemens – is honored to...
Abivax to Present at the 39th Annual J.P. Morgan Healthcare Conference Ahead of Major Clinical Milestones
PARIS, FRANCE / ACCESSWIRE / December 21, 2020 / Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing...
DECN to Announce Various Testing Results This Week for Its COVID-19 GenViro! Swift Kit
The company and its CEO thank supporters and remain fully committed; company will also provide a series of GenViro! test...
Peter A. Fields, MD, DC Shares Precautions His Clinic is Taking in Response to COVID-19
The OrthoRegen® Center for Regenerative Orthopedics is taking action to protect patients and staff during the pandemic SANTA MONICA, CA...